Structural and Behavioral Remedies in Pharmaceutical Mergers: EU v. US
12 PM EDT
The program will focus on remedies in pharmaceutical mergers, with a component focusing on structural remedies and how the FTC and EC find suitable buyers for any divestitures (examining, among other items, the tension between looking for new entrants (in a particular narrowly defined market) and experienced firms to replace lost competition (presumably in a broader segment of the market)). The panel will also explore when behavioral remedies are applied.
*Lauren Rackow, Cahill Gordon & Reindel LLP
*Robin Adelstein, Norton Rose Fulbright US LLP
*Gavin Bushell, Baker & McKenzie
*Arthur Stril, European Commission
*James Weiss, Federal Trade Commission
For this and all upcoming events visit https://shop.americanbar.org/eBus/ABAEventsCalendar.aspx
FREE: Antitrust Section Members, Government, Non-profit Employees, Students
$25 Other Non-Members
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://AmBar.org/ATEvents.
The ABA is not seeking CLE credit for this program.
Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.